Purple Guide 2026: What the Latest Medical Changes Mean for Event Safety

Ashley Redfern

The UK events industry is entering a significant period of transition. With updates to the Purple Guide medical chapter and proposed regulatory changes expected from April 2026, event organisers and medical providers alike are being forced to reassess how event healthcare is planned, delivered, and governed.

At Ashley James Medical, we view these developments not as disruption — but as long-overdue clarification of standards within an increasingly complex clinical environment.

One of the most notable evolutions within the Purple Guide is the continued move away from prescriptive staffing tables toward a Medical Needs Assessment (MNA)-driven model. Historically, event medical provision could be guided by attendance-based formulas. That approach is now being replaced by a more nuanced framework that considers the nature of the event, the audience demographics, the site geography, and the clinical risk profile. This reflects a critical reality: two events with identical attendance figures can present vastly different clinical risk profiles. For providers like Ashley James Medical, this reinforces what has always been best practice — clinically-led planning, not numbers-driven assumptions.

Alongside the Purple Guide updates, the UK Government has consulted on changes to healthcare regulation within event settings. A key proposal involves removing certain exemptions under the Health and Social Care Act 2008, which historically allowed some event-based treatment to fall outside formal regulation. The proposed direction points toward more event-based clinical activities being classified as regulated activity, increased requirement for Care Quality Commission (CQC) registration, and greater scrutiny of clinical governance, accountability, and scope of practice. While these proposals are not yet law, the direction is clear: event medicine is moving toward stronger regulatory alignment with mainstream healthcare delivery.

Despite the discussion around 2026 reforms, several core principles remain firmly in place. The event organiser retains overall responsibility for safety. Events must not rely on NHS ambulance services as primary cover. The fundamentals of safe event planning have not changed — only the expectation of how robustly they are applied.

Perhaps the most significant implication of these changes is the elevation of clinical governance. In a less prescriptive environment, the competence of providers, the robustness of governance frameworks, and the quality of documentation and decision-making become decisive. Without structured minimums, there is a real risk of variation in standards across providers. Governance — not job titles, branding, or cost — must define a safe medical provider.

Rather than viewing these changes as a compliance burden, organisers should see this as an opportunity to strengthen their approach: documenting all decisions for SAG, insurers, and legal defensibility, and asking not 'what is the minimum required?' but 'what level of healthcare is clinically appropriate for my risk profile?'

As a clinician-led organisation, Ashley James Medical has always operated ahead of this curve, with a robust clinical governance framework spanning strategy to practice, clear separation between regulated and non-regulated activities, and alignment with JRCALC, Resuscitation Council UK, and national best practice.

The 2026 Purple Guide updates signal a shift toward a more mature, healthcare-aligned events industry. Choose providers based on competence, governance, and clinical credibility — not cost alone. Ashley James Medical provides clinician-led, governance-driven medical services for events, productions, and high-profile environments across the UK. Plan your event with confidence, compliance, and clinical excellence.